A novel stereocontrolled approach has been developed for the syntheses of tashiromine and epitashiromine alkaloids from cyclooctene β-amino acids. The synthetic concept is based on the azetidinone opening of a bicyclic β-lactam, followed by oxidative ring opening through ring C-C double bond and reductive ring-closure reactions of the cis-or trans-cyclooctene β-amino acids.
Introduction
Indolizidine alkaloids are an important class of naturally occurring compounds which have received considerable attention as a result of their valuable physiological properties. A number of representatives of this class exhibit glycosidase inhibitory activity or antimetastatic, anticancer, antitumour or anti-HIV properties [1] [2] [3] . A large number of natural products contain an indolizidine framework, among them (−)-δ-coniceine, (−)-swainsonine, indolizidine 167B [4] [5] [6] [7] [8] [9] [10] , (+)-lentiginosine [11] [12] [13] [14] [15] , (+)-slaframine [16] , (−)-elaeokanine C [17] , (+)-cyclizidine [18] , lepadiformine [19] , the highly oxygenated (+)-castanospermine [20, 21] , or pumiliotoxin [22] . Figure 1 illustrates the structures of several such compounds.
Tashiromine is a natural indolizidine alkaloid isolated from Maackia tashiroi (1990) . Strategies for the synthesis of indolizidine derivatives have received considerable interest from synthetic and medicinal chemists ( Figure 2 ). A number of synthetic approaches have been described earlier for construction of the indolizidine framework; access to tashiromine in racemic form can be achieved through the alkylation of succinimide, followed by ring closure via acyliminium intermediates [23, 24] , the reduction of cyclized pyridinium salts [25] , iminium cascade cyclization [26] , alkyne-mediated hydroformylation-cyclization [27] , or electrophilic pyrolidinone alkylation followed by ring closure [28, 29] . Pyrrolidine alkylation and nucleophilic ring closure followed by C-C double bond hydroboration [30] leads to racemic epitashiromine, as does the N-alkylated succinimide transformation through the corresponding indolizidinone [31] . Several synthetic procedures have also been developed for the preparation of tashiromine or epitashiromine enantiomers.
(+)-Tashiromine has been synthetized from a pyrrolidinone derivative through chiral Lewis acid-catalysed cyclization to substituted pyrrolidinones [17] , by the intramolecular cyclization of a chiral alkenylated pyrrolidinone, followed by hydroxylation [32] , or by the intramolecular ring closure of chiral pyrrolidine diesters followed by ester and oxo group reduction [33] , while the syntheses of (+)-epitashiromine starts from a chiral morpholine derivative, with nitrone 1,3-dipolar cycloaddition and reduction [34] (Figure 3 ). (−)-Tashiromine has been accessed through the ring closure of difunctionalized acyclic chiral sulfonamide-based β-amino acids [35] , the cyclization of pyrrole derivatives with a chiral side-chain [36] , or the enantioselective arylation of pyrrole, followed by saturation [37] . The transformation of chiral functionalized pyrrole or pyrrolidine derivatives has served as the basis of the construction of (−)-epitashiromine [38, 39] (Figure 4 ).
The oxidative functionalization of cyclic β-amino acid derivatives has been reported to be a convenient route for the preparation of N-heterocyclic β-amino acid derivatives [40, 41] or for the stereocontrolled synthesis of functionalized cispentacins [42] and their acyclic counterparts [43, 44] (Figure 5 ). The oxidative ring cleavage of various vicinal diols and the transformation of the resulting dialdehyde intermediates has been efficiently applied in recent years for the synthesis of a series of valuable organic molecules [45] [46] [47] [48] [49] [50] [51] [52] . In particular, Davies and co-workers have utilized the oxidative ring opening of cyclic vicinal diols followed by ring closure for access to pyrrolizidine alkaloids [45] .
Results and Discussion
We describe here a novel access route for the synthesis of tashiromine and epitashiromine by starting from an unsaturated bicyclic β-lactam. The retrosynthetic concept of the synthesis is represented on Scheme 1 and was based on the lactam ring opening, in continuation followed by oxidative ring opening of the formed β-amino esters and by reductive ring closure as key steps.
Bicyclic β-lactam (±)-1 [53, 54] was first transformed by azetidinone opening to the corresponding amino ester hydrochloride (±)-2 [53, 54] , N-protection of which with benzyl chloroformate (Z-Cl) afforded protected amino ester (±)-3 in 78% yield. In agreement with our earlier observations [40] [41] [42] C-C double bond functionalization of the cyclooctene β-amino ester via dihydroxylation with N-methyl morpholine N-oxide (NMO) in the presence of OsO 4 afforded the corresponding allcis dihydroxylated ethyl β-aminocyclooctanecarboxylate (±)-4 in 90% yield (for dihydroxylation, see also reference [54] ) (Scheme 2). Amino ester (±)-4 was next subjected through its vicinal diol moiety to oxidative ring opening with NaIO 4 in Scheme 2: Synthesis of (±)-tashiromine ((±)-6).
MeOH at 20 °C, which resulted (monitored by TLC) in the corresponding ring-opened unstable diformyl intermediate (I1), which after work-up was immediately used without further purification (for several similar types of acyclic diformyl intermediates, see references [40, 41, 43, 44] ). Thus, the crude material was submitted to catalytic hydrogenolysis and after N-deprotection underwent double cyclization-reduction to furnish indolizidine ester (±)-5 in 41% yield after purification by chromatography.
Reduction of the ester group of (±)-5 with an excess of LiAlH 4 in THF at 20 °C gave the corresponding tashiromine (±)-6 [35] [36] [37] , which was isolated in 48% yield after purification by column chromatography (Scheme 2). The stereochemistry of (±)-6 was unequivocally assigned by NMR data, which were consistent with those reported [35] [36] [37] .
A similar strategy was applied for the synthesis of epitashiromine. On reaction with NaOEt in EtOH at 20 °C, ethyl cis-β-aminocyclooctenecarboxylate (±)-3 underwent epimerization at C-1, leading after 18 h to an equilibrium mixture of cis and trans amino esters (1:1 ratio determined by 1 H NMR on the crude mixture), the required trans isomer (±)-7 being separated from the cis counterpart and isolated in a yield of 48% by means of column chromatography. Dihydroxylation of (±)-7 with NMO/OsO 4 next afforded an oily mixture of cis and trans dihydroxylated cyclooctane β-amino esters (diastereomeric mixture of (±)-8) in 77% overall yield after column chromatography. Our attempts to separate this nearly 1:1 mixture of the two dihydroxylated stereoisomers (determined on the basis of 1 H NMR data) failed, but the mixture could be applied in the next ring-opening oxidation step, since it gave only one openchain diformyl intermediate I2.
Similarly to the cis isomer, this unstable dialdehyde intermediate was subjected without isolation to catalytic hydrogenolysis, followed by reductive cyclization, to give the corresponding indolizidine ester (±)-9 in 40% yield. Finally, ester reduction with LiAlH 4 in THF resulted in epitashiromine (±)-10 [32, 34, 39] in 53% yield after isolation by chromatography (Scheme 3). The stereochemistry of (±)-epitashiromine was assigned by NMR data, which were in agreement with those reported [32, 34, 39] .
Conclusion
In summary, a novel stereocontrolled efficient method has been presented for the synthesis of tashiromine and epitashiromine alkaloids in six or seven steps, based on the preparation of cis or trans cyclooctene β-amino esters, followed by their oxidative ring cleavage and double reductive ring-closure reactions.
Experimental
General procedure for the Z-protection of amino esters
To a solution of amino ester hydrochloride ((±)-2 or (−)-2) [29] (17.8 mmol) in THF (40 mL), Et 3 N (9 mL) was added at 0 °C, followed by 7.8 mL (1 equivalent) of Z-Cl (a 50% solution in toluene). The mixture was stirred for 14 h at 20 °C, and then was diluted with EtOAc (120 mL). The organic layer was washed with H 2 O (3 × 60 mL), dried (Na 2 SO 4 ), and concen- trated under reduced pressure. The crude material was purified by column chromatography on silica gel (n-hexane/EtOAc 4:1), affording the amino ester.
General procedure for the dihydroxylation of amino esters
To a solution of cis or trans Z-protected amino ester ((±)-3, (−)-3 or (±)-7) (2.9 mmol) in acetone (30 mL) and H 2 O (1 mL), NMO (1.5 equivalents) and 2% OsO 4 in t-BuOH (0.7 mL) were added and the mixture was stirred at 20 °C for 4 h. A saturated aqueous solution of Na 2 SO 3 (40 mL) was then added, the mixture was extracted with CH 2 Cl 2 (3 × 30 mL), and the organic layer was dried (Na 2 SO 4 ) and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (n-hexane/EtOAc 1:4) to give the dihydroxylated amino ester.
General procedure for epimerization of the cis-amino ester
To a solution of cis N-protected amino ester ((±)-3 or (−)-3) (3.3 mmol) in EtOH (30 mL), EtONa (1.5 equivalents) was added at 0 °C and the mixture was stirred at 20 °C for 18 h. H 2 O (70 mL) was then added, the mixture was extracted with CH 2 Cl 2 (3 × 30 mL), and the organic layer was dried over Na 2 SO 4 and concentrated under reduced pressure. The crude material was purified by column chromatography on silica gel (n-hexane/EtOAc 9:1) to give the trans isomer as a colourless oil.
General procedure for the oxidative ring opening/reductive ring closure of dihydroxylated amino esters 
General procedure for reduction of the ester
To a solution of indolizidine carboxylate ((±)-5, (±)-9 or (−)-9) (1 mmol) in dry THF (15 mL), LiAlH 4 (5 equivalents) was added at 0 °C and the mixture was stirred at 20 °C for 4 h. It was then cooled to 0 °C, H 2 O (2 mL) was added dropwise and the solid formed was filtered off through Celite. The filtrate was extracted with CH 2 Cl 2 (3 × 15 mL), and the combined organic layers were dried (Na 2 SO 4 ) and concentrated under reduced pressure. The crude oil was purified by column chromatography on silica gel (CH 2 Cl 2 /MeOH/NH 4 OH 90:8:2 or CH 2 Cl 2 / MeOH/NH 4 OH 90:5:5) to give the alkaloid.
Ethyl (1R*,2S*)-2-(benzyloxycarbonylamino)cyclooct-5-enecarboxylate ((±)-3)
A colourless oil (R f 0.6, n-hexane/EtOAc 4:1); yield: 78%; 1 H NMR (400 MHz, CDCl 3 ) δ 1.28 (t, J = 7.1 Hz, 3H, CH 3 ), 
Ethyl (8R*,8aS*)-octahydroindolizine-8-carboxylate ((±)-5)
A yellow oil (R f 0.55, CH 2 
Ethyl (8S*,8aS*)-octahydroindolizine-8-carboxylate ((±)-9)
A yellow oil (R f 0. 45 
